Jazz Pharmaceuticals plc Operating Income
Jazz Pharmaceuticals plc (JAZZ) reported Operating Income of $248.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-03
- Jazz Pharmaceuticals plc operating income (loss) for the quarter ending 2026-06-30 was $248.20M.
- Jazz Pharmaceuticals plc operating income (loss) for the quarter ending 2026-03-31 was $336.60M.
- Jazz Pharmaceuticals plc operating income (loss) for the quarter ending 2025-12-31 was $254.53M, a 33.43% increase year-over-year.
- Jazz Pharmaceuticals plc operating income (loss) for the quarter ending 2025-09-30 was $57.51M, a 77.90% decline year-over-year.
- Jazz Pharmaceuticals plc operating income (loss) for fiscal 2025 was -$430.24M, a 160.04% decline from fiscal 2024.
- Jazz Pharmaceuticals plc operating income (loss) for fiscal 2024 was $716.63M, a 23.86% increase from fiscal 2023.
- Jazz Pharmaceuticals plc operating income (loss) for fiscal 2023 was $578.58M.
- Jazz Pharmaceuticals plc operating income (loss) for fiscal 2022 was -$65.53M, a 138.48% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248.20M 10-Q · filed 2026-08-03 | $584.80M 10-Q · filed 2026-08-03 | $839.34M derived: sum of 3 quarters · filed 2026-08-03 | $896.84M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $336.60M 10-Q · filed 2026-05-05 | $591.13M derived: sum of 2 quarters · filed 2026-05-05 | $648.64M derived: sum of 3 quarters · filed 2026-05-05 | -$37.76M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $254.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $312.04M derived: sum of 2 quarters · filed 2026-02-24 | -$374.36M derived: sum of 3 quarters · filed 2026-08-03 | -$430.24M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $57.51M 10-Q · filed 2025-11-05 | -$628.89M derived: sum of 2 quarters · filed 2026-08-03 | -$684.77M 10-Q · filed 2025-11-05 | -$494.02M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | -$686.40M 10-Q · filed 2026-08-03 | -$686.39M 10-Q · filed 2025-08-06 | -$742.30M 10-Q · filed 2026-08-03 | -$742.28M 10-Q · filed 2025-08-06 | -$551.53M derived: sum of 3 quarters · filed 2026-08-03 | -$291.32M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$55.90M 10-Q · filed 2026-05-05 | -$55.89M 10-Q · filed 2025-05-07 | $134.87M derived: sum of 2 quarters · filed 2026-05-05 | $395.08M derived: sum of 3 quarters · filed 2026-05-05 | $594.52M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $190.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $450.98M derived: sum of 2 quarters · filed 2026-02-24 | $650.42M derived: sum of 3 quarters · filed 2026-02-24 | $716.63M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $260.21M 10-Q · filed 2025-11-05 | $459.65M derived: sum of 2 quarters · filed 2025-11-05 | $525.86M 10-Q · filed 2025-11-05 | $648.36M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $199.44M 10-Q · filed 2025-08-06 | $265.65M 10-Q · filed 2025-08-06 | $388.15M derived: sum of 3 quarters · filed 2026-02-24 | $560.54M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $66.21M 10-Q · filed 2025-05-07 | $188.70M derived: sum of 2 quarters · filed 2026-02-24 | $361.10M derived: sum of 3 quarters · filed 2026-02-24 | $518.73M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $122.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $294.89M derived: sum of 2 quarters · filed 2026-02-24 | $452.52M derived: sum of 3 quarters · filed 2026-02-24 | $578.58M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $172.39M 10-Q · filed 2024-11-07 | $330.03M derived: sum of 2 quarters · filed 2024-11-07 | $456.08M 10-Q · filed 2024-11-07 | $192.70M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $157.64M 10-Q · filed 2024-08-01 | $283.69M 10-Q · filed 2024-08-01 | $20.30M derived: sum of 3 quarters · filed 2025-02-26 | $45.07M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $126.06M 10-Q · filed 2024-05-02 | -$137.33M derived: sum of 2 quarters · filed 2025-02-26 | -$112.57M derived: sum of 3 quarters · filed 2025-02-26 | -$27.02M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | -$263.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$238.62M derived: sum of 2 quarters · filed 2025-02-26 | -$153.08M derived: sum of 3 quarters · filed 2025-02-26 | -$65.53M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $24.76M 10-Q · filed 2023-11-08 | $110.31M derived: sum of 2 quarters · filed 2023-11-08 | $197.86M 10-Q · filed 2023-11-08 | $247.24M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $85.55M 10-Q · filed 2023-08-09 | $173.09M 10-Q · filed 2023-08-09 | $222.47M derived: sum of 3 quarters · filed 2024-02-28 | $250.84M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $87.55M 10-Q · filed 2023-05-10 | $136.93M derived: sum of 2 quarters · filed 2024-02-28 | $165.30M derived: sum of 3 quarters · filed 2024-02-28 | $95.71M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $49.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $77.75M derived: sum of 2 quarters · filed 2024-02-28 | $8.16M derived: sum of 3 quarters · filed 2024-02-28 | $170.28M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $28.37M 10-Q · filed 2022-11-09 | -$41.22M derived: sum of 2 quarters · filed 2022-11-09 | $120.90M 10-Q · filed 2022-11-09 | $294.31M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | -$69.59M 10-Q · filed 2022-08-03 | $92.53M 10-Q · filed 2022-08-03 | $265.94M derived: sum of 3 quarters · filed 2023-03-01 | $462.15M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $162.12M 10-Q · filed 2022-05-04 | $335.53M derived: sum of 2 quarters · filed 2023-03-01 | $531.74M derived: sum of 3 quarters · filed 2023-03-01 | $729.87M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $173.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $369.62M derived: sum of 2 quarters · filed 2023-03-01 | $567.75M derived: sum of 3 quarters · filed 2023-03-01 | $378.07M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $196.21M 10-Q · filed 2021-11-09 | $394.33M derived: sum of 2 quarters · filed 2021-11-09 | $204.66M 10-Q · filed 2021-11-09 | $265.90M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $198.13M 10-Q · filed 2021-08-03 | $8.45M 10-Q · filed 2021-08-03 | $69.70M derived: sum of 3 quarters · filed 2022-03-01 | $202.80M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | -$189.67M 10-Q · filed 2021-05-04 | -$128.43M derived: sum of 2 quarters · filed 2022-03-01 | $4.67M derived: sum of 3 quarters · filed 2022-03-01 | $208.96M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $61.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $194.35M derived: sum of 2 quarters · filed 2022-03-01 | $398.63M derived: sum of 3 quarters · filed 2022-03-01 | $532.37M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $133.10M 10-Q · filed 2020-11-02 | $337.39M derived: sum of 2 quarters · filed 2020-11-02 | $471.13M 10-Q · filed 2020-11-02 | $656.18M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | $204.28M 10-Q · filed 2020-08-04 | $338.03M 10-Q · filed 2020-08-04 | $523.08M derived: sum of 3 quarters · filed 2021-02-23 | $711.86M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | $133.74M 10-Q · filed 2020-05-05 | $318.80M derived: sum of 2 quarters · filed 2021-02-23 | $507.57M derived: sum of 3 quarters · filed 2021-02-23 | $660.77M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | $185.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $373.83M derived: sum of 2 quarters · filed 2021-02-23 | $527.03M derived: sum of 3 quarters · filed 2021-02-23 | $614.84M 10-K · filed 2021-02-23 | ||
| 2018-09-30 | $188.78M 10-Q · filed 2019-11-05 | $341.98M derived: sum of 2 quarters · filed 2019-11-05 | $429.78M 10-Q · filed 2019-11-05 | $570.99M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $153.20M 10-Q · filed 2019-08-06 | $241.01M 10-Q · filed 2019-08-06 | $382.21M derived: sum of 3 quarters · filed 2020-02-25 | $468.67M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $87.81M 10-Q · filed 2019-05-07 | $229.01M derived: sum of 2 quarters · filed 2020-02-25 | $315.47M derived: sum of 3 quarters · filed 2020-02-25 | $480.51M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $141.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $227.66M derived: sum of 2 quarters · filed 2020-02-25 | $392.70M derived: sum of 3 quarters · filed 2020-02-25 | $528.84M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $86.45M 10-Q · filed 2018-11-06 | $251.50M derived: sum of 2 quarters · filed 2018-11-06 | $387.64M 10-Q · filed 2018-11-06 | $553.14M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | $165.04M 10-Q · filed 2018-08-07 | $301.18M 10-Q · filed 2018-08-07 | $466.69M derived: sum of 3 quarters · filed 2019-02-26 | $602.94M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $136.14M 10-Q · filed 2018-05-08 | $301.64M derived: sum of 2 quarters · filed 2019-02-26 | $437.90M derived: sum of 3 quarters · filed 2019-02-26 | $606.63M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2016-12-31 | $165.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $301.76M derived: sum of 2 quarters · filed 2019-02-26 | $470.49M derived: sum of 3 quarters · filed 2019-02-26 | $591.65M 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $136.25M 10-Q · filed 2017-11-07 | $304.99M derived: sum of 2 quarters · filed 2017-11-07 | $426.15M 10-Q · filed 2017-11-07 | $532.78M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $168.74M 10-Q · filed 2017-08-08 | $289.90M 10-Q · filed 2017-08-08 | $396.52M derived: sum of 3 quarters · filed 2018-02-27 | $528.06M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $121.16M 10-Q · filed 2017-05-09 | $227.79M derived: sum of 2 quarters · filed 2018-02-27 | $359.32M derived: sum of 3 quarters · filed 2018-02-27 | $512.62M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $106.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $238.16M derived: sum of 2 quarters · filed 2018-02-27 | $391.46M derived: sum of 3 quarters · filed 2018-02-27 | $508.22M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $131.53M 10-Q · filed 2016-11-08 | $284.83M derived: sum of 2 quarters · filed 2016-11-08 | $401.59M 10-Q · filed 2016-11-08 | $531.51M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $153.30M 10-Q · filed 2016-08-09 | $270.06M 10-Q · filed 2016-08-09 | $399.98M derived: sum of 3 quarters · filed 2017-02-28 | $458.01M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $116.76M 10-Q · filed 2016-05-10 | $246.68M derived: sum of 2 quarters · filed 2017-02-28 | $304.71M derived: sum of 3 quarters · filed 2017-02-28 | $379.00M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $129.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $187.96M derived: sum of 2 quarters · filed 2017-02-28 | $262.25M derived: sum of 3 quarters · filed 2017-02-28 | $195.59M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $58.04M 10-Q · filed 2015-11-09 | $132.33M derived: sum of 2 quarters · filed 2015-11-09 | $65.67M 10-Q · filed 2015-11-09 | $160.17M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $74.29M 10-Q · filed 2015-08-05 | $7.63M 10-Q · filed 2015-08-05 | $102.13M derived: sum of 3 quarters · filed 2016-02-23 | $202.69M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | -$66.66M 10-Q · filed 2015-05-07 | $27.84M derived: sum of 2 quarters · filed 2016-02-23 | $128.40M derived: sum of 3 quarters · filed 2016-02-23 | $205.47M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | $94.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $195.06M derived: sum of 2 quarters · filed 2016-02-23 | $272.13M derived: sum of 3 quarters · filed 2016-02-23 | $340.31M 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $100.56M 10-Q · filed 2014-11-04 | $177.63M derived: sum of 2 quarters · filed 2014-11-04 | $245.81M 10-Q · filed 2014-11-04 | $313.19M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $77.07M 10-Q · filed 2014-08-05 | $145.25M 10-Q · filed 2014-08-05 | $212.63M derived: sum of 3 quarters · filed 2015-02-24 | $267.93M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $68.19M 10-Q · filed 2014-05-08 | $135.57M derived: sum of 2 quarters · filed 2015-02-24 | $190.87M derived: sum of 3 quarters · filed 2015-02-24 | $230.29M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-31 | $67.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $122.68M derived: sum of 2 quarters · filed 2015-02-24 | $162.11M derived: sum of 3 quarters · filed 2015-02-24 | $197.84M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $55.30M 10-Q · filed 2013-11-05 | $94.73M derived: sum of 2 quarters · filed 2013-11-05 | $130.47M 10-Q · filed 2013-11-05 | $168.13M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $39.43M 10-Q · filed 2013-08-06 | $35.46M 10-Q · filed 2012-08-07 | $75.17M 10-Q · filed 2013-08-06 | $68.64M 10-Q · filed 2012-08-07 | $112.83M derived: sum of 3 quarters · filed 2014-02-25 | $146.53M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $35.74M 10-Q · filed 2013-05-07 | $33.19M 10-Q · filed 2012-05-08 | $73.40M derived: sum of 2 quarters · filed 2014-02-25 | $107.11M derived: sum of 3 quarters · filed 2014-02-25 | $140.97M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2011-12-31 | $37.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $71.37M derived: sum of 2 quarters · filed 2014-02-25 | $105.23M derived: sum of 3 quarters · filed 2014-02-25 | $127.83M 10-K · filed 2014-02-25 | ||
| 2011-09-30 | $33.70M 10-Q · filed 2012-11-09 | $67.56M derived: sum of 2 quarters · filed 2012-11-09 | $90.17M 10-Q · filed 2012-11-09 | $115.70M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-06-30 | $33.86M 10-Q · filed 2012-08-07 | $56.46M 10-Q · filed 2012-08-07 | $82.00M derived: sum of 3 quarters · filed 2013-02-26 | $96.44M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-03-31 | $22.60M 10-Q · filed 2012-05-08 | $48.14M derived: sum of 2 quarters · filed 2013-02-26 | $62.58M derived: sum of 3 quarters · filed 2013-02-26 | $73.16M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2010-12-31 | $25.54M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $39.98M derived: sum of 2 quarters · filed 2013-02-26 | $50.56M derived: sum of 3 quarters · filed 2013-02-26 | $57.79M 10-K · filed 2013-02-26 | ||
| 2010-09-30 | $14.44M 10-Q · filed 2011-11-08 | $25.02M derived: sum of 2 quarters · filed 2011-11-08 | $32.25M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | $10.58M 10-Q · filed 2011-08-03 | $17.81M 10-Q · filed 2011-08-03 | ||||
| 2009-12-31 | $15.93M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |